Nostrum Biodiscovery Solutions

Discover

Whether you are focusing on small molecules, enzymes, or biologics, our AI-powered molecular design methods offer the most efficient screening of extensive libraries.

De novo Design

Design your ideal molecule from scratch – whether it is a protein, ligand, enzyme, or nucleic acid. Our advanced active learning generative models, fueled by diverse data sources, ensure unmatched
performance.

Optimize

Leverage our expertise and proprietary platform to optimize any molecule, enhancing its activity, specificity, ADMET properties, and more.

Why Our Solutions Stand Out

We combine our proprietary Molecular Modeling software, with innovative AI tools to deliver highly specialized and efficient solutions.

Technology Publications

Our technology

PELE:

Our proprietary Monte-Carlo based algorithm for molecular modeling

AI algorithms developed for molecular modeling

Nostrum Collaborative Approach

Services

Leave the work to us while you retain full IP rights

Licensing

Leverage our proprietary software with full licensing options

Co Development

Working hand-in-hand and sharing IP

Year Founded

Projects Undertaken

Clients

CAGR (2Y)

About

Nostrum Biodiscovery is a spin-off from the Barcelona Supercomputing Center (BSC-CNS) and the Institute for Research in Biomedicine (IRB), two of the most recognized Spanish international research centers.

Our two areas of focus : therapeutics and bio-based chemistry.

Our customer-tailored solutions are based on state-of-the-art proprietary and 3rd-party software, combined with the latest development on AI. We use best in-class Molecular Modeling for data augmentation and fine-tuning of dedicated machine-learning algorithms.

We have now clients in more than 13 countries and are currently expanding in Asia, Latin America while strengthening our presence in the US and Europe.

See the team

News

Technology

Our Polyplat proprietary platform for effective polypharmacology.

See a short presentation on the concept and technologies behind our Polyplat solution.

LINK

Publication

Springer nature
June 2023

Polypharmacology: promises and new drugs in 2022.

Ryszkiewicz, P., Malinowska, B. & Schlicker, E. Pharmacol. Rep 75, 755–770 (2023).

LINK

Interview

Interview with our CSO Victor Guallar on polypharmacology.

Victor talks about what is polypharmacology and how it will change the future of drug design.

LINK

Our clients

Get in touch

Inquiries

For any inquiries, questions, or collaborations, please feel free to reach out to us. You can either call us at the provided number or fill out the contact form, and we will get back to you promptly.

Contact Us


We’re looking for talented people

Come and join us for an exciting job in one of the most innovative and growing biotech in Europe.